526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹14
- High
- ₹14
- 52 Week Low
- ₹10
- 52 Week High
- ₹38
- Open Price₹14
- Previous Close₹14
- Volume97,447
Investment Returns
- Over 1 Month -10.91%
- Over 3 Month + 12.45%
- Over 6 Month -10.62%
- Over 1 Year -62.61%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -8.2
- PEG Ratio
- 0
- Market Cap Cr
- 62
- P/B Ratio
- Average True Range
- 0.99
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.05
- RSI
- 42.4
- MFI
- 42.99
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹13.64
-0.47
(-3.33%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹14.14
- 50 Day
- ₹14.08
- 100 Day
- ₹14.49
- 200 Day
- ₹18.18
Resistance and Support
13.83
- R3 15.05
- R2 14.72
- R1 14.16
- S1 13.27
- S2 12.94
- S3 12.38
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹13 As on 13 December, 2025 | 00:30
The Market Cap of Indrayani Biotech is ₹62.1 Cr As on 13 December, 2025 | 00:30
The P/E ratio of Indrayani Biotech is -8.2 As on 13 December, 2025 | 00:30
The PB ratio of Indrayani Biotech is 0.8 As on 13 December, 2025 | 00:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.